<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/399f" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/399f/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/399f/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_399f"><akn:num>399f</akn:num><akn:heading>Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepre</akn:heading><akn:content><akn:p>§ 399f. Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups(a) Communication planThe Secretary of Health and Human Services (referred to in this section as the “Secretary”), acting through the Commissioner of Food and Drugs, shall review and modify, as necessary, the Food and Drug Administration’s communication plan to inform and educate health care providers and patients on the benefits and risks of medical products, with particular focus on underrepresented subpopulations, including racial subgroups.


(b) ContentThe communication plan described under subsection (a)—(1) shall take into account—(A) the goals and principles set forth in the Strategic Action Plan to Reduce Racial and Ethnic Health Disparities issued by the Department of Health and Human Services;

(B) the nature of the medical product; and

(C) health and disease information available from other agencies within such Department, as well as any new means of communicating health and safety benefits and risks related to medical products;


(2) taking into account the nature of the medical product, shall address the best strategy for communicating safety alerts, labeled indications for the medical products, changes to the label or labeling of medical products (including black-box warnings, health advisories, health and safety benefits and risks), particular actions to be taken by health care professionals and patients, any information identifying particular subpopulations, and any other relevant information as determined appropriate to enhance communication, including varied means of electronic communication; and

(3) shall include a process for implementation of any improvements or other modifications determined to be necessary.


(c) Issuance and posting of communication plan(1) Communication planNot later than 1 year after July 9, 2012, the Secretary, acting through the Commissioner of Food and Drugs, shal</akn:p></akn:content><akn:subsection eId="subsec_399f_a"><akn:num>(a)</akn:num><akn:heading>Communication plan</akn:heading><akn:content><akn:p>(a) Communication plan The Secretary of Health and Human Services (referred to in this section as the “Secretary”), acting through the Commissioner of Food and Drugs, shall review and modify, as necessary, the Food and Drug Administration’s communication plan to inform and educate health care providers and patients on the benefits and risks of medical products, with particular focus on underrepresented subpopulations, including racial subgroups.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_399f_b"><akn:num>(b)</akn:num><akn:heading>Content</akn:heading><akn:content><akn:p>(b) Content The communication plan described under subsection (a)—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_399f_c"><akn:num>(c)</akn:num><akn:heading>Issuance and posting of communication plan</akn:heading><akn:content><akn:p>(c) Issuance and posting of communication plan</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>